7 Ondansetron and Related 5-HT3 Antagonists: Recent Advances
- 1 January 1992
- book chapter
- Published by Elsevier
- Vol. 29, 239-270
- https://doi.org/10.1016/s0079-6468(08)70010-9
Abstract
No abstract availableThis publication has 64 references indexed in Scilit:
- 5-Hydroxytryptamine (5-HT3) receptor antagonists. 1. Indazole and indolizine-3-carboxylic acid derivativesJournal of Medicinal Chemistry, 1990
- Identification and Characterisation of 5‐Hydroxytryptamine3 Recognition Sites in Human Brain TissueJournal of Neurochemistry, 1989
- Electrophysiology of 5-HT3 receptors in neuronal cell linesTrends in Pharmacological Sciences, 1989
- BRL 43694: A Novel Antiemetic to Prevent Nausea and Vomiting Induced by ChemotherapyJNCI Journal of the National Cancer Institute, 1988
- Identification and distribution of 5-HT3 receptors in rat brain using radioligand bindingNature, 1987
- The action of dazopride to enhance gastric emptying and block emesisNeuropharmacology, 1987
- FIRST RESULTS WITH ICS 205-930 (5-HT3 RECEPTOR ANTAGONIST) IN PREVENTION OF CHEMOTHERAPY-INDUCED EMESISThe Lancet, 1987
- 5-hydroxytryptamine m-receptor antagonism to prevent cisplatin-induced emesisNeuropharmacology, 1986
- Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamineNeuropharmacology, 1986
- Reactions of silyl enol ethers and lactone enolates with dimethyl(methylene)ammonium iodide. The bis-.alpha.-methylenation of pre-vernolepin and pre-vernomeninJournal of the American Chemical Society, 1976